KQW-20169-25201
3 vaccinations
4 coded responses
28 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 452 / OH
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Moderna
-
2020-12-31
Registered in v-safe
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-15
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-26
- 2021-03-05
- 2021-03-10
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Common cold - runny nose, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-28
-
2021-09-25
Dose 3 — Moderna
-
2021-10-24
Survey response — day 28, dose 3MedDRA: Adverse reaction — Feeling: GoodFree text: Systemic reaction after 3rd doseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — day 35, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-06
- 2021-12-25
- 2022-03-27
-
2022-09-26
Survey response — 12 months, dose 3MedDRA: Ovarian cyst — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ovarian cystMedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-09-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-09-25 | Moderna | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 8 — 3 months, dose 2
Symptoms: Common cold - runny nose, congestion
Release 10 — day 28, dose 3
Symptoms: Systemic reaction after 3rd dose
Release 10 — day 35, dose 3
Symptoms: Pregnancy
Release 12 — 12 months, dose 3
Symptoms: Ovarian cyst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release